Registration of securities issued in business combination transactions

Balance Sheets (Mymd Pharmaceuticals Inc.)

v3.20.4
Balance Sheets (Mymd Pharmaceuticals Inc.) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash $ 18,617,955 $ 517,444
Total Current Assets 36,842,761 10,310,814
Total Assets 36,842,761 10,884,935
LIABILITIES AND STOCKHOLDER'S DEFICIT    
Trade accounts payable 569,999 599,306
Total Current Liabilities 2,263,295 1,529,765
Total Liabilities 2,263,295 1,529,765
Stockholders' Deficit    
Common stock value 171,598,681 128,920,414
Accumulated Deficit (137,163,739) (119,583,130)
Total Stockholders' Deficit 34,579,466 9,355,170
Total Liabilities and Stockholders' Deficit 36,842,761 10,884,935
Mymd Pharmaceuticals Inc. [Member]    
Current Assets:    
Cash 133,733 132,023
Prepaid expenses and other current assets 1,218 17,472
Total Current Assets 134,951 149,495
Intangible Assets 18,334
Total Assets 134,951 167,829
LIABILITIES AND STOCKHOLDER'S DEFICIT    
Trade accounts payable 1,025,063 878,620
Due to Related Party 39,177 14,577
Accrued interest, related party 175,679 10,639
Loan Payable, related party 1,200,000
Payroll Protection Program Loan 54,000
Total Current Liabilities 2,493,919 903,836
Line of credit, related party, net of unamortized debt discount 1,734,237 990,355
Total Liabilities 4,228,156 1,894,191
Stockholders' Deficit    
Common stock value 4,004 3,806
Additional Paid in Capital 43,411,488 36,848,064
Accumulated Deficit (47,508,697) (38,578,232)
Total Stockholders' Deficit (4,093,205) (1,726,362)
Total Liabilities and Stockholders' Deficit $ 134,951 $ 167,829